Cargando…

Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response

High-risk, cancer-causing human papillomaviruses (HPV) cause infections of the epidermis that may progress to cancer, including cervical cancer. Viral persistence, contributed to by viral evasion of the host immune response, is associated with the likelihood of cancer developing. Langerhans cells (L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, J., Burn, C., Young, K., Wilson, M., Ly, K., Budhwani, M., Tschirley, A., Braithwaite, A., Baird, M., Hibma, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799164/ https://www.ncbi.nlm.nih.gov/pubmed/29402982 http://dx.doi.org/10.1038/s41598-018-20779-2

Ejemplares similares

Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice
por: Jemon, K., et al.
Publicado: (2016)

The Mouse Papillomavirus Epigenetic Signature Is Characterised by DNA Hypermethylation after Lesion Regression
por: Tschirley, Allison M., et al.
Publicado: (2021)

An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy
por: Jemon, Khairunadwa, et al.
Publicado: (2013)

Langerhans Cell Homeostasis and Activation Is Altered in Hyperplastic Human Papillomavirus Type 16 E7 Expressing Epidermis
por: Abd Warif, Nor Malia, et al.
Publicado: (2015)

Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
por: D'Costa, Zarina J., et al.
Publicado: (2012)

The Immune Response to Papillomavirus During Infection Persistence and Regression
por: Hibma, Merilyn H
Publicado: (2012)

Cytotoxic and Immunochemical Properties of Viscumin Encapsulated  in Polylactide Microparticles
por: Kolotova, E.S., et al.
Publicado: (2012)

p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical Cancer Cells
por: Zhuang, Linhan, et al.
Publicado: (2020)

T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation
por: Woodham, Andrew W., et al.
Publicado: (2016)

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
por: Mashima, Hiroaki, et al.
Publicado: (2020)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

Mesoporous Silicon Microparticles Enhance MHC Class I Cross-Antigen Presentation by Human Dendritic Cells
por: Jiménez-Periáñez, A., et al.
Publicado: (2013)

Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16
por: Ki, Eun Young, et al.
Publicado: (2016)

Integration of human papillomavirus type 16 in cervical cancer cells
por: Gudleviciene, Zivile, et al.
Publicado: (2014)

Human papillomavirus-16 infection and p16 expression in oral squamous cell carcinoma
por: Tokuzen, Norihiko, et al.
Publicado: (2021)

Growth Dependence of Human Papillomavirus 16 DNA‐positive Cervical Cancer Cell Lines and Human Papillomavirus 16‐Transformed Human and Rat Cells on the Viral Oncoproteins
por: Watanabe, Sumie, et al.
Publicado: (1993)

A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2016)

CpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells
por: Jung, Heejung, et al.
Publicado: (2018)

P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
por: Tenzer, S, et al.
Publicado: (2009)

P16-32. Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells
por: Cellerai, C, et al.
Publicado: (2009)

Human papillomavirus 16 infection in adenocarcinoma of the cervix
por: Chew, G K, et al.
Publicado: (2005)

Leukemia Inhibitory Factor Downregulates Human Papillomavirus-16 Oncogene Expression and Inhibits the Proliferation of Cervical Carcinoma Cells
por: Bay, Joseph M., et al.
Publicado: (2011)

Dissecting regulatory T cell expansion using polymer microparticles presenting defined ratios of self-antigen and regulatory cues
por: Bridgeman, Christopher J., et al.
Publicado: (2023)

Cell-derived microparticles and the lung
por: Nieri, Dario, et al.
Publicado: (2016)

Target Cell Cyclophilins Facilitate Human Papillomavirus Type 16 Infection
por: Bienkowska-Haba, Malgorzata, et al.
Publicado: (2009)

Human papillomavirus type 16 E6 induces cell competition
por: Brimer, Nicole, et al.
Publicado: (2022)

Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8(+) T Cell Immunity
por: Camp, Faye A., et al.
Publicado: (2022)

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response
por: Weir, Genevieve M, et al.
Publicado: (2014)

Microparticles as antigenic targets in human and murine SLE
por: Ullal, Anirudh, et al.
Publicado: (2012)

Correction: CpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells
por: Jung, Heejung, et al.
Publicado: (2019)

Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients
por: Bera, T K, et al.
Publicado: (2018)

Detection of Human Papillomavirus Type 16 DNA and Papillomavirus Genus‐specific Antigens in Vulva and Cervix from Patients with Bowenoid Papulosis
por: Sugase, Motoyasu, et al.
Publicado: (1989)

Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells
por: Costa, Marcilia P., et al.
Publicado: (2016)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen
Publicado: (1982)

T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia
por: Steele, J C, et al.
Publicado: (2005)

CD8 T-Cell Responses in Incident and Prevalent Human Papillomavirus Types 16 and 18 Infections
por: Coleman, Hannah N., et al.
Publicado: (2012)

P16-33. Standardized serum-free cryomedia have minimum cytotoxicity and maintain antigen-specific T-cell response
por: Schulz, JC, et al.
Publicado: (2009)

Acute cytotoxic effects of silica microparticles used for coating of plastic blood-collection tubes on human periosteal cells
por: Masuki, Hideo, et al.
Publicado: (2020)

Localisation of Human Papillomavirus 16 E7 Oncoprotein Changes with Cell Confluence
por: Laurson, Joanna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b0ra19dmugpo308l41sljpkn6v